These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38244985)

  • 1. Reply to Pendyal-Long-term Adverse Outcomes in Black Women With Obstructive Coronary Artery Disease: A Study of the Women's Ischemia Syndrome Evaluation (WISE) Cohort.
    Luu JM; Bairey Merz CN; Wei J
    Can J Cardiol; 2024 Jun; 40(6):1177. PubMed ID: 38244985
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-Term Adverse Outcomes in Black Women With Ischemia and No Obstructive Coronary Artery Disease: A Study of the WISE (Women's Ischemia Syndrome Evaluation) Cohort.
    Luu JM; Malhotra P; Cook-Wiens G; Pepine CJ; Handberg EM; Reis SE; Reichek N; Bittner V; Wei J; Kelsey SF; Sailaja Marpuri R; Sopko G; Bairey Merz CN
    Circulation; 2023 Feb; 147(7):617-619. PubMed ID: 36780383
    [No Abstract]   [Full Text] [Related]  

  • 3. Anginal symptoms, coronary artery disease, and adverse outcomes in Black and White women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.
    Eastwood JA; Johnson BD; Rutledge T; Bittner V; Whittaker KS; Krantz DS; Cornell CE; Eteiba W; Handberg E; Vido D; Bairey Merz CN
    J Womens Health (Larchmt); 2013 Sep; 22(9):724-32. PubMed ID: 23992103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project.
    Gulati M; Cooper-DeHoff RM; McClure C; Johnson BD; Shaw LJ; Handberg EM; Zineh I; Kelsey SF; Arnsdorf MF; Black HR; Pepine CJ; Merz CN
    Arch Intern Med; 2009 May; 169(9):843-50. PubMed ID: 19433695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-Year Mortality in the WISE Study (Women's Ischemia Syndrome Evaluation).
    Kenkre TS; Malhotra P; Johnson BD; Handberg EM; Thompson DV; Marroquin OC; Rogers WJ; Pepine CJ; Bairey Merz CN; Kelsey SF
    Circ Cardiovasc Qual Outcomes; 2017 Dec; 10(12):. PubMed ID: 29217675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratory.
    Sharaf B; Wood T; Shaw L; Johnson BD; Kelsey S; Anderson RD; Pepine CJ; Bairey Merz CN
    Am Heart J; 2013 Jul; 166(1):134-41. PubMed ID: 23816032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Adverse Outcomes in Black Women With Obstructive Coronary Artery Disease: A Study of the Women's Ischemia Syndrome Evaluation (WISE) Cohort.
    Luu JM; Cook-Wiens G; Pepine CJ; Handberg EM; Reis SE; Bittner V; Sopko G; Bairey Merz CN; Wei J
    Can J Cardiol; 2023 Nov; 39(11):1664-1666. PubMed ID: 37897475
    [No Abstract]   [Full Text] [Related]  

  • 8. Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.
    Chen Q; Reis SE; Kammerer CM; McNamara DM; Holubkov R; Sharaf BL; Sopko G; Pauly DF; Merz CN; Kamboh MI;
    Am J Hum Genet; 2003 Jan; 72(1):13-22. PubMed ID: 12454802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure hospitalization in women with signs and symptoms of ischemia: A report from the women's ischemia syndrome evaluation study.
    Bakir M; Nelson MD; Jones E; Li Q; Wei J; Sharif B; Minissian M; Shufelt C; Sopko G; Pepine CJ; Merz CNB
    Int J Cardiol; 2016 Nov; 223():936-939. PubMed ID: 27589041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse Pregnancy Outcomes Are Associated with Reduced Coronary Flow Reserve in Women With Signs and Symptoms of Ischemia Without Obstructive Coronary Artery Disease: A Report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction Study.
    Park K; Quesada O; Cook-Wiens G; Wei J; Minissian M; Handberg EM; Merz NB; Pepine CJ
    J Womens Health (Larchmt); 2020 Apr; 29(4):487-492. PubMed ID: 31859580
    [No Abstract]   [Full Text] [Related]  

  • 11. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study.
    Pepine CJ; Anderson RD; Sharaf BL; Reis SE; Smith KM; Handberg EM; Johnson BD; Sopko G; Bairey Merz CN
    J Am Coll Cardiol; 2010 Jun; 55(25):2825-32. PubMed ID: 20579539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of phosphodiesterase type 5 inhibition on microvascular coronary dysfunction in women: a Women's Ischemia Syndrome Evaluation (WISE) ancillary study.
    Denardo SJ; Wen X; Handberg EM; Bairey Merz CN; Sopko GS; Cooper-Dehoff RM; Pepine CJ
    Clin Cardiol; 2011 Aug; 34(8):483-7. PubMed ID: 21780138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Coronary Endothelial and Microvascular Dysfunction in Women with Symptoms of Ischemia and No Obstructive Coronary Artery Disease Is Confirmed by a New Cohort: The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD).
    Anderson RD; Petersen JW; Mehta PK; Wei J; Johnson BD; Handberg EM; Kar S; Samuels B; Azarbal B; Kothawade K; Kelsey SF; Sharaf B; Shaw LJ; Sopko G; Bairey Merz CN; Pepine CJ
    J Interv Cardiol; 2019; 2019():7169275. PubMed ID: 31772544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Even "WISE-R?"-an Update on the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation.
    Barsky L; Merz CNB; Wei J; Shufelt C; Handberg E; Pepine C; Rutledge T; Reis S; Doyle M; Rogers W; Shaw L; Sopko G
    Curr Atheroscler Rep; 2020 Jun; 22(8):35. PubMed ID: 32556630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicted Versus Observed Major Adverse Cardiac Event Risk in Women With Evidence of Ischemia and No Obstructive Coronary Artery Disease: A Report From WISE (Women's Ischemia Syndrome Evaluation).
    Sedlak T; Herscovici R; Cook-Wiens G; Handberg E; Wei J; Shufelt C; Bittner V; Reis SE; Reichek N; Pepine C; Bairey Merz CN
    J Am Heart Assoc; 2020 Apr; 9(7):e013234. PubMed ID: 32268814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIMI frame count and adverse events in women with no obstructive coronary disease: a pilot study from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Petersen JW; Johnson BD; Kip KE; Anderson RD; Handberg EM; Sharaf B; Mehta PK; Kelsey SF; Merz CN; Pepine CJ
    PLoS One; 2014; 9(5):e96630. PubMed ID: 24800739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of risk profiles of participants in the Women's IschemiA TRial to Reduce events In non-ObstRuctive CAD (WARRIOR) trial, using Coronary Computed Tomography Angiography vs Invasive Coronary Angiography.
    Lakshmanan S; Wei J; Cook-Wiens G; Pepine CJ; Handberg EM; Shaw LJ; Budoff M; Merz CNB
    Prog Cardiovasc Dis; 2024; 84():90-93. PubMed ID: 38547955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudden Cardiac Death in Women With Suspected Ischemic Heart Disease, Preserved Ejection Fraction, and No Obstructive Coronary Artery Disease: A Report From the Women's Ischemia Syndrome Evaluation Study.
    Mehta PK; Johnson BD; Kenkre TS; Eteiba W; Sharaf B; Pepine CJ; Reis SE; Rogers WJ; Kelsey SF; Thompson DV; Bittner V; Sopko G; Shaw LJ; Bairey Merz CN
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women.
    AlBadri A; Bairey Merz CN; Johnson BD; Wei J; Mehta PK; Cook-Wiens G; Reis SE; Kelsey SF; Bittner V; Sopko G; Shaw LJ; Pepine CJ; Ahmed B
    J Am Coll Cardiol; 2019 Feb; 73(6):684-693. PubMed ID: 30765035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anger, hostility, and cardiac symptoms in women with suspected coronary artery disease: the Women's Ischemia Syndrome Evaluation (WISE) Study.
    Krantz DS; Olson MB; Francis JL; Phankao C; Bairey Merz CN; Sopko G; Vido DA; Shaw LJ; Sheps DS; Pepine CJ; Matthews KA
    J Womens Health (Larchmt); 2006 Dec; 15(10):1214-23. PubMed ID: 17199462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.